A new study from Exact Sciences and Mayo Clinic released by the American Association of Cancer Research shows a new blood-based test could make detecting lung cancer a more reliable process.
“These results reveal an opportunity to detect lung cancer from a simple blood draw,” said Kevin Conroy, chairman and CEO of Exact Sciences, which is currently marketing a home colon cancer test. “Our collaboration with Mayo Clinic is efficiently identifying biomarkers for additional cancer applications on the same technology platform as Cologuard.”
AACR released the abstract of the study, which involved multiple rounds of testing on almost 400 patients, on Wednesday.
See full story at WisBusiness.com
